CRVL vs UNH vs CVS vs CI vs HUM

For growth investors, CorVel Corporation (CRVL) is the stronger pick with 12.

6% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Cigna Corporation (CI) offers the better valuation at 12. 8x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cigna Corporation (CI) is the cheapest at 12.

8x versus CVS Health Corporation at 62. 8x. On forward P/E, Cigna Corporation is actually cheaper at 9. 4x.

Over the past 5 years, CorVel Corporation (CRVL) delivered a total return of +45.

7%, compared to -43. 3% for Humana Inc. (HUM). Over 10 years, the gap is even starker: CRVL returned +267. 5% versus CVS's +3. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

05β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1059% more volatile than CVS relative to the S&P 500. On balance sheet safety, CorVel Corporation (CRVL) carries a lower debt/equity ratio of 9% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CorVel Corporation (CRVL) is pulling ahead at 12.

6% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CorVel Corporation (CRVL) is the more profitable company, earning 10.

6% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 10. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRVL leads at 13. 5% versus 1. 1% for HUM. At the gross margin level — before operating expenses — CRVL leads at 23. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Cigna Corporation (CI) trades at 9.

4x forward P/E versus 33. 4x for CorVel Corporation — 24. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CI: 15. 5% to $328. 00.

In this comparison, CVS (3.

1% yield), UNH (2. 4% yield), CI (2. 1% yield), HUM (1. 4% yield) pay a dividend. CRVL does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), 3. 1% yield). Both have compounded well over 10 years (CVS: +3. 5%, CRVL: +267. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CRVL (Financial Services) and UNH (Healthcare) and CVS (Healthcare) and CI (Healthcare) and HUM (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CRVL is a small-cap quality compounder stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; CI is a mid-cap deep-value stock; HUM is a mid-cap quality compounder stock. UNH, CVS, CI, HUM pay a dividend while CRVL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.